Translation of Good Laboratory Practice Study Reports: Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 21, 2023
August 10, 2024
d24a7556-16d8-47e2-86bf-ca971a9ef59d
Related Documents
Labeling for Biosimilar and Interchangeable Biosimilar Products
Guidance DocumentSeptember 18, 2023Center for Drug Evaluation and Research
Considerations for Complying with 21 CFR 211110
Guidance DocumentJanuary 6, 2025Center for Drug Evaluation and Research
Good Review Management Principles and Practices for New Drug Applications and Biologics License Applications: Draft Guidance for Industry and Review Staff
Guidance DocumentSeptember 25, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.